Subscribe to Newsletter
Manufacture Advanced Medicine

The Cell + Gene Curator

| James Strachan

Looking back on 12 months of cell and gene therapy research.

Manufacture Vaccines

COVID-19: Vaccine Development at Full Tilt

| Sheila Rocchio

Will the rapid development of COVID-19 vaccines lead to unsafe therapies?

Business & Regulation Business Practice

Building a Beautiful Biotech

| James Strachan

Sitting Down With… Vered Caplan, CEO of Orgenesis, Israel.

Manufacture Advanced Medicine

Surveying China’s CAR T Boom

Our infographic examines China's CAR T therapy development.

Manufacture Bioprocessing - Upstream & Downstream

Advancing ADC Development

Can prodrug payloads lead to a new dawn for antibody drug conjugates?

Business & Regulation Business Practice

Celebrating Great British Pharma

| Cheryl Teoh

Why the UK can hold its head high in the drive for pharma innovation.

Business & Regulation Advanced Medicine

Spreading the Cell and Gene Word

| James Strachan

The Cell and Gene Collective launches to help boost patient access and awareness of cell and gene therapies.

Manufacture Supply Chain

Infographic: Green Progress

This infographic on biopharma cold chain reveals green goals for a more sustainable future.

Business & Regulation Business Practice

Business-In-Brief

Criminal charges, drug pricing, and upgraded headquarters… What’s new in business?

Manufacture Business Practice

Is it Time to Reevaluate Our Priorities?

| James Strachan

The COVID-19 vaccines demonstrate what’s possible when disease is tackled as a genuine priority.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register